In the longer term, the two firms plan to use PlexBio's multiplexing technology to develop a full menu of infectious disease assays.
The Gastrointestinal Pathogen Panel is the first of a number of planned infectious disease syndromic panels on the firm's PCR-based system.
The acquisition merges OvaGene's liquid biopsy technology and molecular diagnostics with Etta's point-of-care system.
The assay was demonstrated to be as effective as microscopy and a rapid immunoassay at detecting Plasmodium falciparum in a sample of febrile patients in Nigeria.
Building on a recent point-counterpoint in the Journal of Clinical Microbiology, lab directors discuss pros and cons of large MDx panels for infectious disease testing.
Originally published May 7.
Strong sales of its clinical systems and consumables pushed the firm's top line up 35 percent, while Cepheid turned in its third consecutive quarter of GAAP profitability.
The acquisition is expected to help build Myriad's companion diagnostics franchise.
York University researchers find genomic evidence of inbreeding in the yellow-banded bumblebee, according to Reuters.
In its survey of US adults, the Pew Research Center finds that views on the genetic engineering of animals depend on why it's done.
The Scientist reports agricultural researchers are working on a gene-stacking tool.
In Nature this week: statistical method for overcoming case-control imbalance issues, and more.